X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TEVA PHARMA (Israel) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   TEVA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-18
TEVA PHARMA
Dec-13
PIRAMAL ENTERPRISES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,0832,880-   
Low Rs1,9022,502-   
Sales per share (Unadj.) Rs589.71,652.7-  
Earnings per share (Unadj.) Rs284.0103.2-  
Cash flow per share (Unadj.) Rs310.5236.8-  
Dividends per share (Unadj.) Rs25.0090.38-  
Dividend yield (eoy) %1.03.4 29.9%  
Book value per share (Unadj.) Rs1,467.01,835.8-  
Shares outstanding (eoy) m180.27848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x4.21.6 259.6%   
Avg P/E ratio x8.826.1 33.7%  
P/CF ratio (eoy) x8.011.4 70.7%  
Price / Book Value ratio x1.71.5 115.9%  
Dividend payout %8.887.5 10.1%   
Avg Mkt Cap Rs m449,3322,281,637 19.7%   
No. of employees `0006.844.9 15.2%   
Total wages/salary Rs m19,8810-   
Avg. sales/employee Rs Th15,535.631,181.7 49.8%   
Avg. wages/employee Rs Th2,905.40-   
Avg. net profit/employee Rs Th7,482.51,947.9 384.1%   
INCOME DATA
Net Sales Rs m106,3101,401,463 7.6%  
Other income Rs m2,5950-   
Total revenues Rs m108,9061,401,463 7.8%   
Gross profit Rs m51,599383,791 13.4%  
Depreciation Rs m4,773113,282 4.2%   
Interest Rs m29,78327,527 108.2%   
Profit before tax Rs m19,638242,983 8.1%   
Minority Interest Rs m2,8011,104 253.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-159,505 0.0%   
Tax Rs m-28,764-2,967 969.6%   
Profit after tax Rs m51,20387,548 58.5%  
Gross profit margin %48.527.4 177.2%  
Effective tax rate %-146.5-1.2 11,997.3%   
Net profit margin %48.26.2 771.0%  
BALANCE SHEET DATA
Current assets Rs m118,154946,543 12.5%   
Current liabilities Rs m462,260825,465 56.0%   
Net working cap to sales %-323.78.6 -3,746.6%  
Current ratio x0.31.1 22.3%  
Inventory Days Days2791 29.3%  
Debtors Days Days4796 48.5%  
Net fixed assets Rs m113,727457,749 24.8%   
Share capital Rs m3613,450 10.5%   
"Free" reserves Rs m264,0930-   
Net worth Rs m264,4541,556,759 17.0%   
Long term debt Rs m242,206716,599 33.8%   
Total assets Rs m726,8343,202,792 22.7%  
Interest coverage x1.79.8 16.9%   
Debt to equity ratio x0.90.5 199.0%  
Sales to assets ratio x0.10.4 33.4%   
Return on assets %11.13.6 310.1%  
Return on equity %19.45.6 344.3%  
Return on capital %10.34.9 209.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,8130-   
CASH FLOW
From Operations Rs m-159,666223,321 -71.5%  
From Investments Rs m-17,677-79,132 22.3%  
From Financial Activity Rs m186,503-267,888 -69.6%  
Net Cashflow Rs m9,364-123,699 -7.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.99 Rs / USD

Compare PIRAMAL ENTERPRISES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PIRAMAL ENTERPRISES With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC LTD.  NATCO PHARMA  



Today's Market

Indian Indices Continue Uptrend, Jet Airways in Focus and Other Top Stocks in Action Today(Pre-Open)

On Monday, share markets in India opened on a positive note and ended the day in green after a volatile day of trading.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Mar 18, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - FRESENIUS KABI ONCO. COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS